Main Story
-
POET Technologies Recaps Highlights of CEO’s Update on Commercial Activities and Provides Results of 2026 AGM
TORONTO, June 30, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today reported the voting results of its Annual General Meeting (the “AGM”), which was held virtually on Friday,…
Travel
Automobile
Tech
Entertainment
-

Dance Without Borders: BYU Ballroom Dance Gives Historic Performances in India
New Delhi | Bengaluru, India The BYU Ballroom Dance Company lit up stages in India for the first time, enchanting over 1,000 audience members with show-stopping performances held on 4 and 6 June 2026 in the nation’s capital and a grand finale in Bengaluru on 9 June. Distinguished guests, including government, interfaith, and community leaders,…
Health
-
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in treatment-naïve infants zero to six months of age in the Baby-COMET phase 3 study Sanofi intends to submit the data to support a regulatory application in the…
-

GLOBAL MITOCHONDRIAL HEALTH SUMMIT 2026 POSITIONS MITOCHONDRIAL HEALTH AS THE FOUNDATION OF HEALTHSPAN
Sydney and Kuala Lumpur events unite world-leading experts as Mitochondrial Health gains recognition as a defining force in healthy ageing, and healthspan Researchers and clinicians identify Ubiquinol as a foundational nutrient in the Mitoceuticals category, supporting mitochondrial function throughout life, from preconception to healthy ageing SYDNEY, June 29, 2026 /PRNewswire/ — The inaugural global Mitochondrial Health…
-
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa Hopledo® is already approved and marketed in the United States as CREXONT®, providing established regulatory and commercial experience as the therapy advances toward European approval More than…
-
TBoostExperts.com Announces Availability of 2026 Consumer Report on Testosterone Booster Supplements and Men’s Health Supplement Evaluation
NEW YORK,USA, June 27, 2026 (GLOBE NEWSWIRE) — TBoostExperts.com today announced the availability of its 2026 Consumer Research Report on testosterone booster supplements and men’s health supplement evaluation, a newly published educational resource developed to help adult consumers better understand how to review supplement labels, ingredient disclosures, dosage transparency, product claims, and company information before…
-

Frost & Sullivan Institute Honors Organizations Driving Transformative Impact Through Visionary Leadership
SILICON VALLEY, Calif., June 26, 2026 /PRNewswire/ — The Frost & Sullivan Institute is proud to announce the recipients of the 2026 Visionary Growth Leadership Best Practices Recognition, honoring organizations that are setting new benchmarks for business leadership by tackling some of the world’s most critical challenges. This recognition celebrates enterprises that have successfully aligned…
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.



















